ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

New Jersey Center To Have Two Alliances: One With CINJ—and One With MD Anderson

June 21, 2013

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

RFAs Available

February 23, 1996